SEATTLE, WA, Nov. 8, 2011 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY)
announced today that the company will be presenting at the Lazard
Capital Markets 8th Annual Healthcare Conference in New York on Tuesday, November 15, 2011
at 9:30 a.m. Eastern Standard Time.
A live and archived webcast of the presentation will be accessible by
visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
Oncothyreon is a biotechnology company specializing in the development
of innovative therapeutic products for the treatment of cancer.
Oncothyreon's goal is to develop and commercialize novel synthetic
vaccines and targeted small molecules that have the potential to
improve the lives and outcomes of cancer patients. For more
information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.
For further information:
Investor and Media Relations Contact: